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Background: The influence on the treatment response in patients with low back pain (LBP) and neck pain (NP) is
unknown. The aim of the study was to investigate the influence of body weight in patients with low back pain
(LBP) and neck pain (NP) on baseline and end of treatment disability.
Methods: Cross-sectional analysis of baseline factors. Longitudinal analysis of prospectively collected patient information
at an outpatient physical therapy registry (data from June 2010 to December 2012). WHO-BMI classification was used:
underweight, lean, overweight, obesity class I, obesity class II and III. The influence of body weight and a predefined set of
confounders was analyzed by multiple regression models.
Results: In LBP, disability increased with increasing BMI [lean = reference, obesity class I Beta 5.41 (95 % CI 0.75; 10.07),
obesity class II-III Beta 7.58 (95 % CI 2.13; 13.03)]. Compared to lean patients, disability after treatment improved in
overweight subjects [Beta −3.90 (95 % CI −7.4; −0.41)] but not in subjects with obesity class II–III [Beta 3.43 (95 % CI −3.81;
10.68)]. There were insufficient patients in the sample with severe obesity and therefore this trend has to be confirmed.
The likelihood for meaningful important change (MID) was similar in all BMI subgroups. For patients with NP, BMI
was not associated with baseline disability, and did not predict end of treatment disability or the likelihood of a
MID. These findings must be interpreted with caution as BMI subgroups did not meet the required sample size.
Conclusion: Overweight and obesity are associated with higher levels of disability before treatment in LBP
patients, but not in NP. In severely obese patients class II–III with LBP the rate of MID was lowest indicating that
these patients experienced the least treatment response compared to the other groups. Further studies should
address the impact of severe obesity on the prognosis of LBP. In patients with LBP, severe obesity may be an
important factor to consider during the physical therapy treatment. In particular, combined treatment strategies
combining weight management, cardiovascular fitness, and low back pain rehabilitation should be investigated.Background
The prevalence of obesity has been steadily increasing
since the 1960s. Currently about one third of the adult
U.S. population is obese [1]. The implications for the
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work-related musculoskeletal disorders [3]. It has been
suggested that obesity is associated with more spinal pain,
mainly low back pain (LBP) [4] and neck pain (NP) [5].
The cost of spinal pain for the US workforce is estimated
at $20 billion annually [6]. Together, obesity and spinal
pain represent two clinically and economically important
public health problems that drive health care utilization.
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mon problem. The lifetime prevalence for LBP exceeds
80 % and for NP ranges between 40 and 70 % [7, 8]. With
LBP every fifth patient will eventually develop chronic
pain-related disability and generate two- thirds of the
direct and indirect costs [7]. While the prognosis in the
early course of LBP is good, return to full function is diffi-
cult to achieve once the condition becomes chronic [7].
NP is frequently persistent [9, 10] and both NP and LBP
have high rates of recurrence [7, 9, 10]. While the body of
research describing the management of LBP is more ro-
bust than that for NP, in cases of nonspecific neck or LBP,
it appears that similar treatment strategies may be benefi-
cial [11, 12]. Research has shown that early screening can
identify individuals at risk for chronicity [13]. Therefore,
patients at risk for chronic spinal pain should be identified
early for targeted treatment interventions that may im-
prove outcomes, most specifically, preventing disabling
pain and chronicity [14].
Obese individuals, compared to lean individuals, are
more likely to experience NP and LBP [5, 15, 16], are ex-
pected to have a slower recovery [17–19], and are more
likely to seek healthcare for LBP [19]. This suggests that
not only might it cost more to treat obese patients but
also that obesity might be a prognostic factor for long-
term functional limitations [20] and increased health care
expenditure. Therefore further exploration is needed to
better understand these phenomena.
Different treatment approaches are available for man-
aging spinal pain [7, 12]. Several prognostic and mediating
factors have been identified that might hinder treatment
success. For example, psychological factors, such as, for
example, fear avoidance, have been shown to negatively in-
fluence treatment efficacy in patients with LBP [21, 22].
There is clear evidence that a biopsychosocial approach to
care, focusing on activity and managing fears and other
emotional issues related to the pain results in best out-
comes including functional restoration, decreased health
care utilization, and reduced direct and indirect costs [13].
Yet few studies have addressed the influence of obesity on
treatment response in spinal rehabilitation and among
those that have, the findings were inconsistent [23–27].
Therefore, it is unclear how obesity affects disability and
treatment response in patients with nonspecific LBP or NP.
The aim of this analysis is to investigate the influence of
body weight on disability in patients with spinal pain and
to explore the influence of body weight on functionally-
related outcomes in individuals undergoing best-evidence
rehabilitation. We hypothesize that obese patients experi-
ence more disability compared to lean patients. We further
hypothesize that body weight is inversely correlated
with functional outcomes after treatment for nonspe-
cific NP and LBP pain. The analysis is based on pro-
spectively collected patient information from anoutpatient rehabilitation clinic registry in New York
City, New York, USA [28].
Methods
Design
This study is a cross-sectional analysis of baseline factors
and longitudinal analysis of prospectively collected patient
information during outpatient physical therapy. The de-
scription of the study inclusion process and the analysis
was based on the guidelines for reporting observational
studies, as described in the Strengthening The Reporting
of Observational studies in Epidemiology (STROBE) state-
ment [29].
Eligibility criteria
All treatment records of subjects treated for LBP and
NP at an urban outpatient rehabilitation facility were po-
tentially eligible for the analysis. Included were all records
of patients 18 years and older who reported weight and
height and perceived disability. Excluded were records
without information on body weight or height, as no body
mass index (BMI) could be calculated, or those missing
reports of perceived disability.
Data collection process of the clinic registry
The data used for the current analysis were collected
between June 2010 and December 2012 at the NYU
Hospital for Joint Diseases Occupational and Industrial
Orthopaedic Center (OIOC), New York University
Langone Medical Center (NYLMC), New York, U.S.A.
The OIOC is an outpatient center of excellence and
provides outpatient physical therapy services for the
management of musculoskeletal conditions, specializing
in spine-related musculoskeletal disorders. Patients are re-
ferred by specialists, insurance companies, and primary
care physicians from the tri-state area (New York, New
Jersey, Connecticut), and represent a wide spectrum of the
working and non-working population in this region.
As part of routine clinical practice, all OIOC patients
provide a core set of information and complete a series
of self-reported validated questionnaires before the start
of treatment, during treatment, and at discharge [28].
This data is used by clinicians to inform treatment deci-
sions, and assess treatment effectiveness. The collected
parameters are based on the recommendations of a con-
sensus statement by Pincus et al. [30] aimed at enhancing
quality in outcome measurements. The data collected re-
flects the patients’ self-report of function, pain, demo-
graphic, psychosocial, and psychological factors that
previous research has found to be relevant to treatment
outcome [30].
The questionnaire forms are scanned or entered directly
into a recording system. All data is de-identified when
entered into the registry database of the International
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lows HIPAA compliance practices related to the security
of data. Researchers involved in the analysis of the de-
identified data were not involved in the data collection
process and did not have access to any personal identifiers
collected by the spine clinic.
Treatment
All patients with NP and LBP at the OIOC receive an
evidence-based approach to care including four to eight
weeks of active physical therapy, and spine education
and information [12, 33]. All treatment is provided by
physical therapists specially trained in a multidisciplinary
approach to care for spinal patients. Treatment takes
place at the spine clinic approximately twice a week for
one hour. Evidence suggests that patients with neck and
back pain should be encouraged to remain active. Exercise
prescription was based in this ideology and was customized
for patients based on evidence of muscle weakness and
tightness, and moderated within tolerable limits. Patients
were educated that they need not be fearful of some degree
of discomfort during exercise. All exercise for the neck and
back comprehensively addressed both some degree of
cardiovascular training combined with stretching and
strengthening the spine and extremities based on individ-
ual presentation. In addition, all patients are instructed in
self-care techniques that include avoidance of bed rest,
activities as tolerated, ice or heat as needed, over the
counter medications for symptom control, and relaxation
techniques. A progressive daily home back exercise pro-
gram is part of the treatment and patients are expected to
exercise independently. The program is customized by the
treating physical therapist based on the specific physical
presentation of the patient. Treatment progress is assessed
on a regular basis by the multidisciplinary team, consisting
of a physician, psychologist, and physical therapists. As
part of treatment, yellow flags are monitored and ad-
dressed by the PT. Yellow flags refer to psychosocial
barriers to recovery. Physical therapists in this setting
were trained to address yellow flags during the course
of rehabilitation. In patients with persistent yellow flags
despite the physical therapist intervention to address
the distress and fears were referred to a health psych-
ologist, who is a part of the interdisciplinary treatment
team at the clinic.
End of treatment assessment
The OIOC registry includes the collected forms of all
patients evaluated at the spine clinic. Completing the
forms was voluntarily, yet was a routine part of the intake
process. Some patients were seen only for an evaluation as
they chose not to start a treatment program or no ap-
proval by the insurance company was obtained. Therefore,
more baseline than end of treatment assessments wereavailable. Furthermore, some patients chose not to self-
report their body weight or height and were therefore not
included in this analysis. The baseline characteristics of all
patients were compared to the patients included in this
analysis for any indication of bias. Patients that underwent
treatment and chose to complete an end of treatment
questionnaire were included in this analysis. Treatment
duration was calculated based on the baseline assessment
date and the date of the completed end of treatment form.
The treatment was stopped when 1) it was no longer ne-
cessary, 2) there was no further coverage by the insurance
companies, 3) the patient chose not to pursue treatment,
or 4) the patient was non- compliant with the recommen-
dations of the therapists.
Outcome definition
The primary outcome was patient-reported disability as
assessed by the Oswestry Disability Index [ODI [34]] for
patients with LBP and the neck disability index (NDI)
for patients with NP [35]. Both, the ODI and the NDI
are widely used, valid, and reliable questionnaires that
measure disability in spine pain patients. The ODI and
the NDI consist of 10 questions (each item score 0 to 5).
The score ranges from 0 to 100 % [(total scored/total
possible score) * 100]. For the longitudinal analysis, a
meaningful clinically important difference (MCID) in the
ODI or NDI was defined as a change of 30 % [36].
Body mass index classes
Self-reported body weight and height at baseline were
used to calculate the BMI, which is computed by kilo-
grams per square meter (kg/m2). Patients were classified
according to the WHO classification [37]: underweight
(BMI < 18 kg/m2), lean (BMI 18- <25 kg/m2), overweight
(BMI 25- <30 kg/m2), obesity class I (BMI ≥ 30 - <35 kg/
m2), obesity class II and III (≥35 kg/m2).
Confounders
The following potential confounders were defined a priori
in an interdisciplinary group consensus and by consulting
the relevant literature [30, 38]: Age, gender, currently not
in a relationship, blue collar workers (e.g. craft or trades
worker, elementary workers), low education (high school
or lower education), not working (because of the medical
condition, ill health, or pain) or working limited duty or
alternate job because of the medical condition, receiving
workers’ compensation, high baseline pain [Numeric
Rating Scale (NRS), range 0–10 [39]]. High baseline
pain was defined as NRS of more than 6 points, chronic
pain as more than 3 months pain duration.
Fear avoidance beliefs were assessed by using the vali-
dated Fear Avoidance Beliefs Questionnaire [FABQ [40]].
The scale has been shown to be valid and reliable and con-
sists of two sub-scales. The fear of work (FABQ-W) sub-
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more fear avoidance beliefs. A cut-off for FABQ-W of >25
has been proposed [41]. The fear of physical activity sub-
scale (FABQ-P) ranges from 0-24 points. A FABQ-P cut-off
of >15 points is suggested [41]. Both cut-points were associ-
ated with a worse prognosis in LBP [41].
Sample size calculation
We calculated the required sample size for subgroups in
a longitudinal analysis comparing the lean patients with
the obese patients, assuming a 20 % difference between
the groups in change in ODI/NDI over time. With a
power of 80 % and a level of significance of 5 %, this re-
sults in 28 patients per group. Anticipating a drop-out
rate of 15 %, this would require the inclusion of at least
33 patients per group at baseline.
Statistical Analysis
Descriptive statistics included median and interquartile
range for the continuous parameters, and percentages
for the categorical outcomes. Results are presented in
categories of the LBP cross-sectional, LBP longitudinal,
NP cross-sectional, and NP longitudinal analyses. Results
of the linear models are presented with the estimate and
the corresponding 95 % confidence interval (95 % CI).
Description of the process used for variable selection
The above described confounders were defined a priori
based on an interdisciplinary consensus and by consulting
the relevant literature [30, 38].
Multiple imputation and variable selection including
interactions
Complete data sets were available for ODI, NDI, and
BMI. Because of missing values in the confounders (re-
sults section: percentage missing between 5 and 23 % in
cross-sectional analysis), we multiply imputed the data-
set (m = 5). The chained equation approach was used
and the five datasets were stacked into one “long” data
file. We used the approach proposed by Rothman et al.
to consider a confounder if a variable changes the effect
of the determinant on the outcome by more than 10 %
[42]. Therefore, we fitted linear regression models to the
outcome in this stacked dataset with BMI as the deter-
minant, well aware of the fact that the estimated coeffi-
cient of BMI is not affected by the stacking of the
dataset (the stacking only affects the standard error of
the estimated coefficient). Among the set of potential
confounders, we evaluated each variable added to the
determinant BMI for a change in the determinant’s effect
size of more than +/- 10 %. If the added variable changed
the estimated BMI effect more than 10 %, it was included
in the final multiple regression model as a confounding fac-
tor. For each outcome, a set of confounders was identifiedwith this approach. Finally, the interaction of the
confounders with the BMI subgroups was tested for
significance.
Fitting of the final multiple linear regression model
When we fitted the final multiple regression models, in-
cluding the determinant BMI and the set of confounders,
to the outcomes or change in outcomes over time, we used
Rubin’s formula for the combination of effect estimates and
their standard errors from the multiply imputed datasets.
We additionally evaluated each confounder for the pres-
ence of an interaction term with BMI. The interaction was
deleted from the model, if it was not significantly different
from zero.
Statistical analyses were conducted by using the statis-
tical software R [43] and the R-package “mice.”
Ethics statement
This study is based on administrative de-identified data
handled in compliance with HIPPA and NYULMC regu-
lations. According to the IRB at NYU, given the nature
of the study, no approval was necessary.
Results
All patients who present to the OIOC clinic for an
evaluation completed intake questionnaires on a voluntary
basis. Between June 2010 and December 2012, a complete
baseline data set for ODI, NDI, and BMI data was avail-
able for the cross-sectional analysis in 739 patients (548
LBP and 191 NP). Not all patients started treatment after
the first evaluation. Most frequently patients chose not to
start a treatment program or no approval by the insurance
company was obtained. In total, 211 LBP and 71 NP
patients received treatment with an end of treatment
evaluation and were included in the longitudinal analysis
(Fig. 1). A description of the baseline characteristics of the
study population is shown in Table 1. For comparison,
Appendix 1 is a description of these same baseline charac-
teristics for all 805 LBP and 256 NP patients. As there was
great variability in the number of subjects per BMI class, a
summary of subjects per group is shown in Table 2. In
LBP the rate of end of treatment assessment was 45 % in
underweight patients, 42 % in lean patients, 40 % in over-
weight patients, 33 % in obese class I patients, and 25 % in
obese class II–III patients. In NP the rate of end of treat-
ment assessment was 67 % in underweight patients, 35 %
in lean patients, 39 % in overweight patients, 32 % in
obese class I, and 38 % in obese class II–III. A BMI-
related effect might have not been detected (Type II error)
for those BMI subgroups that did not meet sample size re-
quirements for subgroup analysis. Treatment duration
was similar for patients with LBP and patients with NP
(median 44 and 46 days respectively).
Fig. 1 Study Flow
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In the LBP group, at baseline, obese patients expressed
more disability [obesity class I Beta 5.41 (95 % CI 0.75;
10.07), obesity class II–III Beta 7.58 (95 % CI 2.13;
13.03)] compared to lean patients (Table 2). Low
education was associated with more disability (Beta
11.20, 95 % CI 5.45; 16.94). The interaction between
obesity class II–III and low education reduced this
effect [Beta −12.33 (95 % CI −22.80; −1.87)]. No other in-
teractions between the predefined confounders and the
BMI classes were found for the LBP group. In patients
with NP, we found no significant influence of BMI cat-
egories on baseline disability (Table 3). Baseline pain (Beta
5.84 95 % CI 3.03; 8.66) and high fear avoidance beliefs of
physical activities (FABQ-P, Beta 4.53 95 % CI 2.07; 6.98)
were associated with more disability. Furthermore, nointeraction between other confounders and BMI were
found.
Results longitudinal analysis
Among patients with LBP, the subgroup “overweight”
was associated with a greater decrease in ODI scores
(decreasing disability) at the end of treatment assessment
[Beta −3.90 (95 % CI −7.4; −0.41)] compared to lean pa-
tients (Table 4). Obesity class II–III was associated with less
reduction in disability at the end of treatment assessment;
however, the confidence interval was wide and not statisti-
cally significant [Beta 3.43 (95 % CI −3.81; 10.68)]. Figure 2
depicts the mean and 95 % CI intervals for ODI at baseline
and the end of treatment assessment in all BMI subgroups.
The results for the obesity class II–III group need to be
interpreted cautiously due to insufficient subjects available
Table 1 Baseline Characteristics of the patient population with reported weight and height
LBP cross-sectional LBP longitudinal Neck cross-sectional Neck longitudinal
General Characteristics
Patients 548 211 191 71
Age: median (IQR) 49 (37; 61) 51 (38; 61) 46 (37; 56) 47 (38; 59)
No age reported: n (%) 28 (5) 2 (1) 14 (7) 0 (0)
Gender female: n (%) 288 (53) 113 (54) 114 (60) 47 (66)
Missing gender information: n (%) 25 (4) 2 (1) 13 (7) 0 (0)
BMI: median (IQR) 26.6 (23.1; 30.2) 26 (22.8; 29.1) 24.8 (22.4; 28.3) 24.7 (22.5; 28.1)
Married or in a relationship: n (%) 229 (42) 90 (43) 81 (47) 34 (48)
No relationship, divorced: n (%) 275 (50) 110 (52) 90 (47) 34 (48)
Not reported: n (%) 44 (8) 11 (5) 20 (11) 3 (4)
Low education (high school): n (%) 126 (23) 45 (21) 28 (15) 13 (18)
Higher education: n (%) 361 (66) 150 (71) 138 (71) 52 (73)
No education reported: n (%) 61 (11) 16 (8) 25 (16) 6 (9)
Insurance Type
Medicare/Medicaid: n (%) 162 (29) 68 (32) 29 (15) 11 (15)
No fault: n (%) 4 (1) 3 (1) 10 (5) 5 (7)
Workers compensation: n (%) 33 (6) 14 (7) 11 (6) 6 (8)
Other (private, others): n (%) 322 (59) 124 (59) 128 (67) 49 (69)
None: n (%) 1 (0.001) 0 (0) 0 (0) 0 (0)
Not reported: n (%) 26 (5) 2 (1) 13 (7) 0 (0)
Occupation
White collar worker: n (%) 159 (29) 62 (29) 71 (37) 24 (34)
Blue collar worker: n (%) 85 (16) 29 (14) 24 (13) 10 (14)
Other: n (%) 0 (0) 0 (0) 0 (0) 0 (0)
Not reported: n (%) 58 (10) 15 (7) 24 (13) 6 (8)
Work Status
Working full time/part time: n (%) 273 (50) 106 (50) 118 (62) 46 (64)
Retired: n (%) 55 (10) 24 (4) 12 (6) 6 (8)
Mainly not working during the last 12 months: n (%) 373 (68) 152 (28) 57 (30) 22 (31)
Currently not working: n (%) 231 (42) 89 (42) 103 (54) 37 (52)
Not working because of ill health or pain: n (%) 95 (17) 40 (19) 20 (10) 7 (10
Not working because of main complaint
Job-related injury: n (%) 28 (5) 13 (6) 10 (5) 1 (1)
Workers compensation case to the main complaint: n (%) 22 (4) 11 (5) 7 (4) 6 (8)
Limited duty: n (%) 18 (3) 7 (3) 4 (2) 1 (1)
Pain-related
Acute: to 6 weeks: n (%) 39 (8) 17 (8) 17 (9) 4 (6)
Subacute: 6 to 12 weeks: n (%) 79 (14) 34 (16) 30 (16) 17 (24)
Chronic: more than 12 weeks: n (%) 363 (66) 137 (65) 119 (62) 46 (65)
No pain duration reported: n (%) 67 (12) 23 (11) 25 (13) 4 (6)
Sciatica/neck and arm pain: n (%) 44 (8) 27 (13) 4 (2) 0 (0)
Time under therapy: median (IQR) days 44 (32; 67) 46 (35; 63)
Self-reported measures
Baseline ODI/NDI: median, IQR 30 (18; 47) 28 (18; 45) 15 (9; 22) 13.3 (10; 20)
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Table 1 Baseline Characteristics of the patient population with reported weight and height (Continued)
End of treatment ODI/NDI: median, IQR – 20 (10; 36) – 10 (5; 15)
No end of treatment ODI/NDI – 13 – 2
Baseline NRS: median, IQR 6 (4; 8) 7 (4; 8) 6 (4; 7) 6 (3; 7)
No baseline NRS 50 17 21 3
End of treatment NRS: median, IQR – 4.5 (3; 7) – 4 (2; 5)
No end of treatment NRS – 165 – 50
Baseline FABQ-W: median, IQR 9 (0; 21) 7 (0; 18) 11 (3; 21) 13 (1; 22)-
High FABQ-W (>25): n (%) 80 (15) 27 (13) 30 (16) 15 (21)
No baseline FABQ-W 57 (10) 26 (12) 24 (13) 3 (4)
End of treatment FABQ-W: median, IQR – 6 (0; 17) – 10 (0; 16)
No end of treatment FABQ-W – – –
Baseline FABQ-P: median, IQR 15 (12; 19) 15 (11; 18) 15 (11; 19) 15 (9; 19)
High FABQ-P (>15): n (%) 231 (42) 92 (44) 75 (39) 18 (25)
No baseline FABQ-P 40 12 20 (10) 2 (2.8)
End of treatment FABQ-P: median, IQR – 12 (6.75, 16.3) – 11 (3; 21)
No end of treatment FABQ-P – 43 – 15 (4.7)
n number of subjects; IQR interquartile range; ODI Oswestry Disability Index (range 0–100), NDI Neck Disability Index (range 0–100); FABQ fear avoidance
questionnaire; FABQ-W work sub-scale (range 0–42); FABQ-P physical activity subscale (range 0–24); BMI body mass index
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founders showed a statistically significant interaction. The
likelihood for a clinical meaningful change in ODI from
baseline to the end of treatment assessment was not differ-
ent between the BMI categories (Table 5).
In patients with NP, none of the tested confounders
predicted the end of treatment NDI (Tables 4 and 5).
NDI values decreased in all groups similarly (Fig. 3).
BMI subgroups were compared to lean patients and pre-
dicted no clinically meaningful change in NDI. Figure 3
illustrates the distribution of NDI with mean and 95 %
CI for the BMI subgroups. The findings of the longitu-
dinal analysis have to be interpreted with caution be-
cause in most sub-groups the sample size requirements
were not met.
Discussion
The analysis of a registry of patients treated for LBP or
NP showed that in LBP, obesity affects clinically importantTable 2 Distribution of the patients according to the BMI subgroup
LBP cross-sectional
Patients: n 548
Underweight (BMI < 18 kg/m2): n (%) 11 (2)a
Lean (BMI 18- < 25 kg/m2): n (%) 198 (36)
Overweight (BMI 25- <30 kg/m2): n (%) 194 (35)
Obesity class I (BMI 30- < 35 kg/m2): n (%) 94 (18)
Obesity class II–III (BMI ≥ 35 kg/m2): n (%) 51 (9)
agroups that did not meet the calculated sample size for sub-group analysis of 33 pfactors. Patients with LBP expressed more disability with
increasing BMI at baseline when compared to lean sub-
jects. During a course of treatment, LBP disability im-
proved more in overweight subjects when compared to
lean patients. In comparison we found in severely obese
patients (obesity class II–III) less improvement in disabil-
ity. While this finding in the severely obese patients was
not statistically different compared to lean patients, the
wide confidence intervals indicate that heterogeneity in
the patient population was present suggesting that further
studies are needed to explain this finding. Independent
prognostic factors for the end of treatment ODI were
baseline ODI and high baseline fear avoidance of physical
activity (FABQ-P).
In NP patients we found no influence of BMI on baseline
disability. Baseline disability was associated with higher pain
scores and higher fear of physical activity beliefs scores.
The only significant prognostic factor for disability at the
end of treatment was the baseline disability. Independents
LBP longitudinal NP cross-sectional NP longitudinal
211 191 71
5 (2)a 6 (3)a 4 (6)a
83 (39) 94 (49) 33 (46)
79 (37) 61 (32) 24 (34)a
31 (15)a 22 (12)a 7 (10)a
13 (6)a 8 (4)a 3 (4)a
atients (power of 80 %, level of significance of 5 %)
Table 3 Results Cross-sectional Analysis for Disability (ODI or NDI)
BMI category Beta (95 % CI) p-value
LBPa Lean (reference) – –
Underweight 3.02 (−8.06; 14.10) 0.59
Overweight 1.17 (−2.17; 4.52) 0.49
Obesity class I 5.41 (0.75; 10.07) 0.02
Obesity class II–III 7.58 (2.13; 13.03) 0.01
Low education 11.20 (5.45; 16.94) 0.00
Blue collar jobs 1.23 (−2.56; 5.01) 0.53
Not working 3.06 (−0.62; 6.73) 0.10
Work-related RF 7.82 (0.33; 15.32) 0.04
High pain baseline 15.59 (12.86; 18.31) 0.00
FABQ-W high 5.30 (−0.13; 10.73) 0.06
FABQ-W N/A 4.98 (0.31; 9.66) 0.04
Underweight x Low education −11.99 (−36.47; 12.50) 0.33
Overweight x Low education −4.48 (−11.94; 2.99) 0.24
Obesity class I x Low education −6.12 (−14.48; 2.25) 0.15
Obesity class II–II x Low education −12.33 (−22.80;−1.87) 0.02
NPb Lean (reference)
Underweight 4.57 (−1.70; 10.83) 0.15
Overweight −1.11 (−3.61; 1.40) 0.38
Obesity class I −0.32 (−3.90; 3.26) 0.86
Obesity class II–III −0.95 (−6.90; 5.00) 0.75
Age −0.04 (−0.13; 0.06) 0.43
Male gender −1.32 (−3.82; 1.19) 0.30
No relationship 2.19 (−0.17; 4.55) 0.07
Blue collar jobs 1.21 (−2.65; 5.07) 0.53
Not working 2.21 (−0.78; 5.20) 0.14
Work-related RF 3.37 (−1.12, 7.85) 0.14
High baseline pain 5.84 (3.03; 8.66) <0.001
High FABQ-P 4.53 (2.07; 6.98) <0.001
High FABQ-W 3.45 (−0.26; 7.15) 0.07
FABQ-W N/A −1.23 (−5.35; 2.89) 0.55
Pre-defined confounders were: low education (high school or less), blue collar jobs includes crafts or trade worker, agricultural or elementary worker, high FABQ-W,
FABQ-W N/A = not working, high pain (NRS > 6), age, gender, not in a relationship
High pain (NRS > 6), FABQ, fear avoidance questionnaire, fear avoidance work sub-scale (FABQ-W) high > 25; fear avoidance beliefs physical sub-scale (FABQ-P)
high >15
Work related risk factor: working full time at alternate or limited duty job because of a medical condition; not working because of pain or ill health; looked but
can’t find a job; not working because of the main complaint in a job-related injury; pending workers compensation case
aConfounder included in the final model when they changed the effect between BMI and ODI/NDI by at least 10 %. Interactions with BMI were included if they
were significantly different from zero (p < 0.05)
bConfounder included in the final model when they changed the effect between BMI and ODI/NDI by at least 10 %. In NP no interactions of confounders with
BMI were found
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baseline NDI, high baseline pain, and high fear avoidance
beliefs of physical activity. However, the findings in the NP
population need to be interpreted with caution as the sam-
ple size requirements for sub-group analyses were not met.
Therefore, we must consider that we might have missed a
relevant influence of BMI on NP-related disability.Results in light of the literature
Whether or not obese patients respond differently to
non-pharmacological treatment approaches for spinal
pain is controversial [25–27, 44]. While one cohort
study found that obese patients responded similarly to
treatment compared to their lean counterparts [44],
other studies found that obesity was associated with a
Table 4 BMI category as prognostic factor for disability (ODI/NDI)
at the end of treatment
BMI category Beta (95 % CI) p-value
LBPa Lean (reference) –
Underweight −4.92 (−18.1; 8.27) 0.45
Overweight −3.90 (−7.4;−0.41) 0.03
Obesity class I −0.83 (−6.1; 4.46) 0.76
Obesity class II–III 3.43 (−3.81; 10.68) 0.35
ODI baseline 0.59 (0.49; 0.69) <0.001
FAB-P high 7.76 (4.39; 11.13) <0.001
FAB-W high −0.82 (−7.1; 5.4) 0.79
FAB-W high NA 2.42 (−2.69)7.53) 0.35
No relationship 3.03 (−0.43; 6.49) 0.09
Work-related RF 3.03 (−2.25; 8.32) 0.25
Chronic pain 4.49 (0.34; 8.64) 0.03
Treatment duration 0.04 (−0.02; 0.09) 0.16
NPa Lean (reference) –
Underweight −0.23 (−6.58; 6.12) 0.94
Overweight 0.91 (−2.23; 4.05) 0.57
Obesity class I −0.46 (−5.39; 4.48) 0.85
Obesity class II–III −4.65 (−11.98; 2.69) 0.21
NDI baseline 0.61 (0.43; 0.78) <0.001
Work-related RF 4.07 (−0.35; 8.48) 0.07
Treatment duration 0.03 (−0.02; 0.08) 0.25
Positive Beta coefficient indicates less decrease in ODI/NDI; negative Beta
coefficient indicates more decrease in ODI/NDI than in the reference group
(lean patients)
aNo significant interactions between BMI and other potential prognostic
factors were found for low back and neck pain patients
All confounders included in the final model changed the influence of BMI on
the outcome ODI/NDI at least 10 % in univariate comparison
Fig. 2 Distribution of ODI at baseline and end of treatment. Raw ODI data:
Ob.II–III, obesity class II–III
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ive studies suggest that obese patients express higher
levels of fear avoidance than their lean counterparts and
therefore are at risk for worse treatment response [25]
and respond poorer to cognitive behavioral therapy, a
treatment aimed at addressing fear of movement [24].
Our findings support that a higher BMI is associated
with more disability at baseline in patients with LBP. A
previously observed interaction between fear avoidance
beliefs and obesity [25] was not found in this study.
Additionally, while overweight subjects with LBP re-
ported higher baseline ODI than lean subjects, the end
of treatment ODI was lower (on average −3.90 points,
95 % CI −7.4; −0.41) and they reported the highest rate
of MID (48 %). The OR for MID was 1.15 and the 95 %
CI crossed 1 and therefore the finding was not statisti-
cally significant (95 % CI 0.99; 1.34). During treatment,
severely obese patients (class II–III) experienced less
decrease in disability than the other groups (+3.43 points
(95 % CI −3.81; 10.68) and had the lowest MID rate
(33 %) indicating that these patients experienced a worse
treatment response compared to the other groups.
Again, the OR for MID was not statistically significant
(OR 1.30 (95 % CI 0.69–2.44). In addition, the rate of
follow-up assessment was 25 % in the severely obese
patients compared to 33 % in obese class I patients and
40 % in overweight patients which may indicate a higher
rate of unfinished treatments in severely obese patients.
It may be hypothesized that overweight patients are
moderately deconditioned and respond well to physical
therapy treatment. Severely obese patients may have, in
addition to LBP, other problems including gait insecurity
and sarcopenia which may require other treatment strat-
egies than those included in their LBP regimen [46].
This finding should be further evaluated in follow-upODI mean and 95 % Cl; Le, lean; Ov, overweight; Ob.I, obesity class I;
Table 5 Results longitudinal analysis for 30 % change as MID in
ODI or NDI
BMI category % with MIDa OR (95 % CI) p-value
LBPb Lean (reference) 36.3 – –
Underweight 33.3 1.19 (0.68; 2.09) 0.63
Overweight 48.0 1.15 (0.99; 1.34) 0.35
Obesity class I 46.4 1.14 (0.92; 1.40) 0.25
Obesity class II–III 33.3 0.98 (0.73; 1.33) 0.91
NP Lean (reference) 41.9
Underweight 50 1.12 (0.58–2.19) 0.73
Overweight 41.7 1.00 (0.72–1.39) 0.98
Obesity class I 57.1 1.03 (0.64–1.64) 0.91
Obesity class II–III 66.7 1.30 (0.69–2.44) 0.41
Results adjusted for the following confounders with at least 10 % change in
the effect between BMI on ODI/NDI
araw rate of MID
bnot in a relationship, blue collar work, not working, work-related risk factor,
chronic LBP, high pain (NRS >6), high FABQ-P
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modifies the treatment response. Our patient population
included insufficient patients with severe obesity to draw
conclusions, and therefore our findings have to be con-
firmed in studies specifically addressing this patient
population. The long-term effects of our findings are un-
known and to the best of our knowledge no study has
been conducted with sufficient numbers of obese pa-
tients to address the question of long-term outcome.
Significant weight reduction has been shown to im-
prove physical and mental outcome for those with LBP
[47]. It has been shown that improved fitness slowed the
decline in mobility in overweight adults with type 2 dia-
betes [48]. It may be that overweight patients are able to
perform recommended spine exercises when comparedFig. 3 Distribution of NDI at baseline and end of treatment. Raw NDI data:
Ob.II–III, obesity class II–IIIto obese and severely obese subjects. Previous research
has shown an association between body fat and the in-
tensity and disability from LBP [49], and that weight re-
duction after bariatric surgery improved joint pain, gait,
and perceived mobility [46]. Severely obese patients with
LBP might start at a state of deconditioning where an
exercise protocol is difficult to follow and the typical
treatment duration may be insufficient for a clinically
important or sustainable effect. Our findings indicate
that further research is needed to study the effect of
body weight on the ability of obese patients with LBP to
participate in exercises, to ascertain the effectiveness of
current treatment strategies and optimal treatment dur-
ation. In addition, the economic impact of a treatment
approach addressing both body weight and LBP may be
substantial and yield better long-term outcomes not
only of LBP but also for other comorbidities associated
with obesity such as cardiovascular and metabolic
disorders.
Only a few studies have addressed the impact of
prognostic factors on NP patients [9, 10, 50], and to the
best of our knowledge, no study has investigated the in-
fluence of body weight on the treatment response in
patients with NP. Our findings concur with epidemio-
logical studies that found no influence of body weight
on disability in NP patients [51]. However, due to the
small patient samples in the BMI subgroups, our find-
ings have to be interpreted with caution and further re-
search is needed to clarify, in particular, the role of
severe obesity on NP.
Strength and limitations
The strength of this study is that all patients treated at
an urban physical therapy clinic with LBP or NP were
included in the analysis. Therefore, this study is based
on real patients in a busy spine pain clinic. Great careNDI mean and 95 % Cl; Le, lean; Ov, overweight; Ob.I, obesity class I;
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heterogeneity by systematically considering evidence-
supported prognostic factors [30]. Subgroup analyses
may lead to both overestimation and underestimation of
an effect. To the best of our knowledge, this is the first
study on the influence of body weight on disability
in spinal pain that used sample size calculation for
subgroup analyses to assess the validity of the re-
sults. Further, all subgroups and prognostic factors
were defined a priori, tests of interaction were per-
formed, and subgroup-specific estimates with the
corresponding confidence intervals are provided to
illustrate the differences.
The following describes three study limitations to
address in follow-up studies. First, the sample size of
patients with NP or LBP followed-up during treatment
was small in the high BMI subgroups (obesity class II–
III). Therefore, wide confidence intervals were ob-
served and the small sample size might explain the
lack of statistically significant findings. Further, the
number of patients who completed the treatment was
very low in some categories and these results need
further confirmation in larger samples. Second, the
data was used from a clinical registry based on self-
reported questionnaires completed on a voluntary
basis. The reported weight and height was not con-
firmed and no further analysis of the body fat distribu-
tion was available. Overweight individuals may report
lower weight and therefore, the BMI in these subjects
may be underestimated. Therefore, the proportion of
obese patients may have been higher in our sample.
While we cannot ignore that obese patients may be
more likely to withhold reporting their body weight,
we found no systematic difference in the baseline
characteristics of all patients included in the registry
and the patients included in this analysis. Third, the
sample size calculation for the subgroup analysis,
based on preset criteria, required a sample size of 33
patients per group for a longitudinal analysis compar-
ing the lean patients with the obese patients. There
were insufficient patients with NP available to rule out
a type 2 error and therefore our findings for the neck
pain population need to be interpreted with caution.Implications for research
Further research should address the influence of se-
vere obesity on the treatment response in patients
with LBP. Our study showed that obese patients with
LBP feel more disabled. Experimental research sug-
gests that obesity is associated with altered muscle
protein synthesis [52]. Further, it has been suggested,
that the presence of obesity-related comorbidities (e.g.
diabetes, hypertension) are associated with moremorbidity and mortality [53, 54]. The influence of
obesity on response to treatment for LBP with and
without the presence of comorbidities should be fur-
ther investigated. Weight loss after bariatric surgery
has been shown to be associated with less LBP, NP,
and other joint pain and may therefore need to be
considered as an added therapeutic strategy in obese
patients with LBP [55]. We found no indication that
obesity was associated with worse treatment outcome
in NP patients. However, the patient sample available for
this analysis was small and this should be addressed in lar-
ger studies.Implications for clinical practice
While our findings have some limitations, they pro-
vide some insight into a patient population treated at
a busy back pain clinic. Our findings indicate that
obese patients with LBP express more disability at
baseline and we found some indication that they may
not recover as well as overweight and lean subjects.
Treatment interventions might therefore incorporate
approaches addressing body weight or use alternative
approaches to exercise routines. It has been shown
that improved fitness slowed the decline in mobility in
overweight adults with type 2 diabetes [48]. Our find-
ings suggest that severe obesity might require specific
guidance and that severely obese patients might ex-
perience more disability associated with LBP when
compared to lean and overweight patients. When not
considered, this might lead to a negative feedback for
the patient and lead to early termination of physical
therapy in these patients and worse outcomes, includ-
ing chronic, disabling pain.Conclusion
Overweight and obesity are associated with higher
levels of disability before treatment in LBP patients,
but not in NP. In obese class II–III patients with LBP,
the rate of MID was lowest, indicating that these pa-
tients experienced worse treatment response com-
pared to the other groups. Further studies should
address the impact of severe obesity on LBP recovery.
In particular, treatment strategies combining weight
management, cardiovascular fitness, physical limita-
tions and low back pain rehabilitation should be
investigated.Availability of supporting data
The data set on which the conclusions of the paper rely
on may be made available upon request.
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LBP cross-sectional LBP longitudinal NP cross-sectional NP longitudinal
General Characteristics
Patients 805 305 256 91
Age: median (IQR) 52 (39; 63) 52 (41; 62) 50 (38; 59) 51 (39; 62)
No age reported 55 9 26 2
Gender female: n (%) 429 (53) 168 (55) 144 (56) 56 (62)
No gender 52 9 25 2
BMI: median (IQR) 26.6 (23.1; 30.2) 26.1 (22.8; 29.1) 24.8 (22.4; 28.3) 24.7 (22.5; 28.1)
No BMI: n (%) 257 (32) 94 (31) 65 (25) 20 (23)
Married or in a relationship: n (%) 321 (40) 130 (43) 99 (39) 43 (47)
No relationship: n (%) 397 (49) 150 (49) 122 (48) 42 (46)
Not reported: n (%) 87 (11) 25 (8) 35 (14) 6 (7)
Low education (no high school diploma): n (%) 75 (9) 19 (6) 10 (4) 2 (2)
High school diploma and higher education: n (%) 609 (76) 248 (81) 196 (74) 74 (81)
No education reported: n (%) 121 (15) 38 (12) 50 (20) 15 (16)
Insurance Type
Medicare/Medicaid: n (%) 275 (34) 104 (34) 51 (19) 19 (21)
No fault: n (%) 5 (0.01) 3 (0.01) 11 (4) 5 (5)
Workers compensation: n (%) 45 (6) 22 (7) 14 (5) 7 (8)
Other (private, others): n (%) 425 (53) 166 (54) 155 (61) 58 (64)
Not reported: n (%) 54 (7) 10 (3) 25 (10) 2 (2)
Occupation
White collar worker: n (%) 212 (26) 82 (27) 88 (34) 29 (32)
Blue collar worker: n (%) 111 (13) 39 (13) 27 (11) 11 (12)
Not reported: n (%) 109 (13) 32 (11) 40 (16) 9 (10)
Work Status
Retired: n (%) 109 (14) 48 (16) 24 (9) 11 (12)
Not working: n (%) 331 (41) 129 (42) 71 (28) 29 (32)
Not working because of ill health or pain: n (%) 128 (16) 52 (17) 24 (9) 9 (10)
Workers compensation case to the main complaint: n (%) 26 (3) 14 (5) 8 (3) 6 (7)
Working full time/part time 367 (46) 146 (48) 144 (56) 55 (60)
Limited duty 21 (3) 7 (2) 6 (2) 2 (2)
Self-reported measures
Baseline ODI/NDI: median, IQR 30 (18; 46) 28.9 (18; 44) 16 (9; 24) 14.4 (9.5; 21.6)
End of treatment ODI/NDI: median, IQR – 22 (10; 35.6) – 11 (4.4; 16.1)
No end of treatment ODI/NDI – 18 – 3
Baseline NRS: median, IQR 6 (4; 8) 6 (4; 8) 6 (3; 8) 6 (3; 8)
No baseline NRS 86 24 30 6
End of treatment NRS: median, IQR – 4 (3; 6) – 4 (2; 5)
No end of treatment NRS – 239 – 68
Baseline FABQ-W: median, IQR 9 (0; 21) 8 (0; 19) 12 (3; 21) 11 (0; 21)
No baseline FABQ-W 153 53 46 10
Table 6 Baseline characteristics of all patients in the OIOC registry (Continued)
End of treatment FABQ-W: median, IQR – 6 (0; 17) – 9 (0; 16.3)
No end of treatment FABQ-W – 82 – 27
Baseline FABQ-P: median, IQR 15 (11; 19) 15 (11; 18) 14 (10; 19) 14.5 (9; 19)
No baseline FABQ-P 64 20 30 3
End of treatment FABQ-P: median, IQR – 12 (6; 17) – 11 (7; 15.8)
No end of treatment FABQ-P – 63 – 21
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